Acurx Pharma to Discuss Fourth Quarter and Full Year 2023 Financial Results
Acurx Announces Positive Clinical Cure Data for Ibezapolstat from Phase 2b Trial
Acurx Announces Positive Microbiology and Microbiome Data for Ibezapolstat
Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference